Peptides which interact with anti-apoptotic members of the Bcl-2 protein family, and uses
US7927813B2 · kind B2 · utility
20Cited by
4References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 31, 2006 |
| Grant date | Apr 19, 2011 |
| Priority date | — |
| Expiry date | Dec 1, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a method of screening and identifying modulators of the protein interaction between new peptides and anti-apoptotic members of the Bcl-2 protein family. The modulators identified on the basis of this method are administered to patients with cancer in order to bring about apoptotic-type and/or autophagic-type programmed cell death in those patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.